News
A paper on the potential of Nichi Glucan to prevent complications of coronavirus infection has been published in a journal.
It argues that Nichiglucan may prevent complications by balancing blood sugar, lipids, and blood clotting.
Participation in CHINA BIO, BIO PHAMA AMERICA and BIO EUROPE
GN Corporation has been selected for JETRO’s participation support program and attends digital exhibitions.
An article on Nichi Glucan was published in Forbes Central America
The article on “Immune response to taking be…
Japanese biomaterials to leverage novel solutions in Urology and Orthopedics
Cover story in Eurobiz Japan, July 2020; Japanese biomaterials to leverage novel solutions in Urology and Orthopedics
We held a press conference in Kochi
After the paper was published, we held a press conference in Kochi…
A webinar on A simple, non-invasive technology of cancer screening by testing saliva, Available in Japan Since 2017
A webinar on A simple, non-invasive technology of cancer screening by testing saliva
NCRM NICHE 2019, an Annual event of NCRM was held on 15th – 16th October, 2019 in Tokyo;
NCRM NICHE 2019, an Annual event of NCRM was held on 15th – 16th October, 2019 in Tokyo
Press Release
The Potential of Nichi Glucan as a Vaccine Adjuvant
A paper describing the potentials of Nichi Glucan as Vaccine
India’s Kasturba University team wins the 15th Fujio Cup Quiz
India’s Kasturba Medical College team won the 15th…
NCRM NICHE 2020 to be held virtually
Date: October 18, 2020
All programs are delivered